Venkataraman Balasubramanian

Array ( [id] => 699796 [patent_doc_number] => 07067683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Industrially applicable process for the sulfamoylation of alcohols and phenols' [patent_app_type] => utility [patent_app_number] => 10/326262 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 0 [patent_no_of_words] => 1831 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067683.pdf [firstpage_image] =>[orig_patent_app_number] => 10326262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7305933 [patent_doc_number] => 20040116359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Pharmaceutical compositions and treatment methods' [patent_app_type] => new [patent_app_number] => 10/329065 [patent_app_country] => US [patent_app_date] => 2002-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 112109 [patent_no_of_claims] => 128 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116359.pdf [firstpage_image] =>[orig_patent_app_number] => 10329065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1175896 [patent_doc_number] => 06747018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-08 [patent_title] => 'Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use' [patent_app_type] => B2 [patent_app_number] => 10/327401 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 31553 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/747/06747018.pdf [firstpage_image] =>[orig_patent_app_number] => 10327401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089684 [patent_doc_number] => 20050009797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Androstane derivative having substituent in 7- abd 17--positions' [patent_app_type] => utility [patent_app_number] => 10/499044 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9461 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009797.pdf [firstpage_image] =>[orig_patent_app_number] => 10499044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303283 [patent_doc_number] => 20040115260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Prolonged release pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/320250 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5351 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115260.pdf [firstpage_image] =>[orig_patent_app_number] => 10320250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697534 [patent_doc_number] => 20030109728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Phosphoric acid isomerization of A 5 (10), 9 (11) - diene steroid to the corresponding 4, 9-diene steriod' [patent_app_type] => new [patent_app_number] => 10/315273 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1821 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109728.pdf [firstpage_image] =>[orig_patent_app_number] => 10315273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6707074 [patent_doc_number] => 20030153808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Implantation rate using ff-mas' [patent_app_type] => new [patent_app_number] => 10/220025 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2354 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153808.pdf [firstpage_image] =>[orig_patent_app_number] => 10220025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865573 [patent_doc_number] => 20030191099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => '17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations' [patent_app_type] => new [patent_app_number] => 10/305418 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12036 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191099.pdf [firstpage_image] =>[orig_patent_app_number] => 10305418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1111327 [patent_doc_number] => 06806263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-19 [patent_title] => 'Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain' [patent_app_type] => B2 [patent_app_number] => 10/304742 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9980 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 349 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806263.pdf [firstpage_image] =>[orig_patent_app_number] => 10304742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386177 [patent_doc_number] => 20040082556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use' [patent_app_type] => new [patent_app_number] => 10/305603 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 77023 [patent_no_of_claims] => 204 [patent_no_of_ind_claims] => 63 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082556.pdf [firstpage_image] =>[orig_patent_app_number] => 10305603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814123 [patent_doc_number] => 20030073673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Hormonal contraceptive product' [patent_app_type] => new [patent_app_number] => 10/299628 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3495 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073673.pdf [firstpage_image] =>[orig_patent_app_number] => 10299628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026399 [patent_doc_number] => 20050020480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/496222 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3126 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020480.pdf [firstpage_image] =>[orig_patent_app_number] => 10496222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6800828 [patent_doc_number] => 20030095992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Method and compositions for temporarily incapacitating subjects' [patent_app_type] => new [patent_app_number] => 10/299027 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8733 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20030095992.pdf [firstpage_image] =>[orig_patent_app_number] => 10299027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856735 [patent_doc_number] => 20030130236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs' [patent_app_type] => new [patent_app_number] => 10/299044 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9487 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130236.pdf [firstpage_image] =>[orig_patent_app_number] => 10299044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846401 [patent_doc_number] => 20030165568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Stabilized steroidal suspension' [patent_app_type] => new [patent_app_number] => 10/275955 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5803 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165568.pdf [firstpage_image] =>[orig_patent_app_number] => 10275955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972591 [patent_doc_number] => 20050038301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Chemical synthesis' [patent_app_type] => utility [patent_app_number] => 10/494987 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5193 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038301.pdf [firstpage_image] =>[orig_patent_app_number] => 10494987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 686868 [patent_doc_number] => 07078396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'Method of treating disorder related to high cholesterol concentration' [patent_app_type] => utility [patent_app_number] => 10/290997 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12090 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078396.pdf [firstpage_image] =>[orig_patent_app_number] => 10290997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847785 [patent_doc_number] => 20030166952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => '13-substituted methacycline compounds' [patent_app_type] => new [patent_app_number] => 10/285975 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8354 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166952.pdf [firstpage_image] =>[orig_patent_app_number] => 10285975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861682 [patent_doc_number] => 20030092690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Novel anti-inflammatory androstane derivatives' [patent_app_type] => new [patent_app_number] => 10/281735 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17093 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092690.pdf [firstpage_image] =>[orig_patent_app_number] => 10281735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946620 [patent_doc_number] => 06964954 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-15 [patent_title] => 'Use of DHEA derivatives on keratinous substances' [patent_app_type] => utility [patent_app_number] => 10/279852 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10126 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/964/06964954.pdf [firstpage_image] =>[orig_patent_app_number] => 10279852 [rel_patent_id] =>[rel_patent_doc_number] =>)